Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #40,451 to #40,500.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Trifectant (2 revisions)
  2. Trifluridine contraindications (2 revisions)
  3. Trifluridine dosage and administration (2 revisions)
  4. Trifluridine labels and packages (2 revisions)
  5. Trifluridine overdosage (2 revisions)
  6. Triglyceride landmark trials (2 revisions)
  7. Triglyceride physiology (2 revisions)
  8. Triiodothyronine (2 revisions)
  9. Trimeperidine (2 revisions)
  10. Trimethoprim (patient information) (2 revisions)
  11. Trimethoprim drug interactions (2 revisions)
  12. Trimethoprim microbiology (2 revisions)
  13. Trimethylaminuria (2 revisions)
  14. Trimix (2 revisions)
  15. Triosephosphate isomerase deficiency (2 revisions)
  16. Tripelennamine (2 revisions)
  17. Triplatin tetranitrate (2 revisions)
  18. Triple test (2 revisions)
  19. Triplet state (2 revisions)
  20. Triquetral fracture (2 revisions)
  21. Tris(2-chloroethyl)amine (2 revisions)
  22. Tritumumab (2 revisions)
  23. Trixatumumab (2 revisions)
  24. Trk receptor (2 revisions)
  25. Troglitazone (2 revisions)
  26. Troisier-Hanot-Chauffard syndrome (2 revisions)
  27. Tropatepine (2 revisions)
  28. Tropical disease (2 revisions)
  29. Tropical spastic paraparesis case study one (2 revisions)
  30. Tropical spastic paraparesis causes (2 revisions)
  31. Tropical spastic paraparesis classification (2 revisions)
  32. Tropical spastic paraparesis cost-effectiveness of therapy (2 revisions)
  33. Tropical spastic paraparesis differential diagnosis (2 revisions)
  34. Tropical spastic paraparesis epidemiology and demographics (2 revisions)
  35. Tropical spastic paraparesis future or investigational therapies (2 revisions)
  36. Tropical spastic paraparesis laboratory findings (2 revisions)
  37. Tropical spastic paraparesis other diagnostic studies (2 revisions)
  38. Tropical spastic paraparesis physical examination (2 revisions)
  39. Tropical spastic paraparesis risk factors (2 revisions)
  40. Tropical spastic paraparesis secondary prevention (2 revisions)
  41. Tropomyosin (2 revisions)
  42. Tropomyosin receptor kinase A (2 revisions)
  43. Troponin C type 1 (2 revisions)
  44. Trotter procedure (2 revisions)
  45. Troxacitabine (2 revisions)
  46. Truncal valve (2 revisions)
  47. Trypanosoma cruzi (2 revisions)
  48. Trypanosome (2 revisions)
  49. Tryptophan hydroxylase (2 revisions)
  50. Tsix (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"